Central Pacific Bank - Trust Division’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.21M Sell
9,589
-205
-2% -$27K 0.12% 172
2026
Q1
$1.36M Sell
9,794
-2,042
-17% -$286K 0.17% 137
2025
Q4
$1.45M Sell
11,836
-1,087
-8% -$132K 0.18% 129
2025
Q3
$1.43M Sell
12,923
-777
-6% -$88.3K 0.17% 132
2025
Q2
$1.52M Buy
13,700
+83
+0.6% +$8.83K 0.19% 119
2025
Q1
$1.53M Sell
13,617
-1,541
-10% -$159K 0.21% 124
2024
Q4
$1.4M Buy
15,158
+894
+6% +$80.5K 0.18% 129
2024
Q3
$1.2M Sell
14,264
-387
-3% -$29.5K 0.15% 155
2024
Q2
$1.01M Buy
14,651
+568
+4% +$37.9K 0.12% 178
2024
Q1
$1.03M Buy
+14,083
New +$1.08M 0.13% 181

Other funds holding GILD

Central Pacific Bank - Trust Division's GILD Position: Q2 2026 in Review

Central Pacific Bank - Trust Division reduced its Gilead Sciences (GILD) stake by 2.1% in Q2 2026, selling an estimated $27K and leaving 9,589 shares worth $1.21M. The position accounts for 0.12% of the portfolio, ranked #172.

Central Pacific Bank - Trust Division first reported a position in GILD in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.53M in Q1 2025. 690 funds tracked by Wall St. Rank hold GILD as of Q2 2026.

  • Central Pacific Bank - Trust Division held 9,589 shares of Gilead Sciences worth $1.21M as of Q2 2026.
  • Central Pacific Bank - Trust Division sold 205 Gilead Sciences shares in Q2 2026, an estimated $27K.
  • Gilead Sciences made up 0.12% of Central Pacific Bank - Trust Division's portfolio in Q2 2026, its #172 holding.
  • Central Pacific Bank - Trust Division first reported a position in Gilead Sciences in Q1 2024 and has held it in 10 quarters since.
  • Central Pacific Bank - Trust Division's Gilead Sciences position peaked at $1.53M in Q1 2025.
  • 690 funds tracked by Wall St. Rank held Gilead Sciences as of Q2 2026.

Based on Central Pacific Bank - Trust Division's 13F filing for Q2 2026, filed 7 Jul 2026.